#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0174] The PCR buffer also contains the deoxyribonucleotide triphosphates (polynucleotide synthesis substrates) dATP, dCTP, dGTP, and dTTP and a polymerase, typically thermostable, all in adequate amounts for primer extension (polynucleotide synthesis) reaction.
1-1	0-1	[	_	_	
1-2	1-5	0174	_	_	
1-3	5-6	]	_	_	
1-4	7-10	The	_	_	
1-5	11-14	PCR	_	_	
1-6	15-21	buffer	_	_	
1-7	22-26	also	_	_	
1-8	27-35	contains	_	_	
1-9	36-39	the	_	_	
1-10	40-59	deoxyribonucleotide	_	_	
1-11	60-73	triphosphates	_	_	
1-12	74-75	(	_	_	
1-13	75-89	polynucleotide	_	_	
1-14	90-99	synthesis	_	_	
1-15	100-110	substrates	_	_	
1-16	110-111	)	_	_	
1-17	112-116	dATP	_	_	
1-18	116-117	,	_	_	
1-19	118-122	dCTP	_	_	
1-20	122-123	,	_	_	
1-21	124-128	dGTP	_	_	
1-22	128-129	,	_	_	
1-23	130-133	and	_	_	
1-24	134-138	dTTP	_	_	
1-25	139-142	and	_	_	
1-26	143-144	a	_	_	
1-27	145-155	polymerase	_	_	
1-28	155-156	,	_	_	
1-29	157-166	typically	_	_	
1-30	167-179	thermostable	_	_	
1-31	179-180	,	_	_	
1-32	181-184	all	_	_	
1-33	185-187	in	_	_	
1-34	188-196	adequate	_	_	
1-35	197-204	amounts	_	_	
1-36	205-208	for	_	_	
1-37	209-215	primer	_	_	
1-38	216-225	extension	_	_	
1-39	226-227	(	_	_	
1-40	227-241	polynucleotide	_	_	
1-41	242-251	synthesis	_	_	
1-42	251-252	)	_	_	
1-43	253-261	reaction	_	_	
1-44	261-262	.	_	_	

#Text=The resulting solution (PCR admixture) is heated to about 90.degree.
2-1	263-266	The	_	_	
2-2	267-276	resulting	_	_	
2-3	277-285	solution	_	_	
2-4	286-287	(	_	_	
2-5	287-290	PCR	_	_	
2-6	291-300	admixture	_	_	
2-7	300-301	)	_	_	
2-8	302-304	is	_	_	
2-9	305-311	heated	_	_	
2-10	312-314	to	_	_	
2-11	315-320	about	_	_	
2-12	321-323	90	_	_	
2-13	323-324	.	_	_	
2-14	324-330	degree	_	_	
2-15	330-331	.	_	_	

#Text=C.-100.degree.
3-1	332-333	C	_	_	
3-2	333-334	.	_	_	
3-3	334-335	-	_	_	
3-4	335-338	100	_	_	
3-5	338-339	.	_	_	
3-6	339-345	degree	_	_	
3-7	345-346	.	_	_	

#Text=C. for about 1 to 10 minutes, preferably from 1 to 4 minutes.
4-1	347-348	C	_	_	
4-2	348-349	.	_	_	
4-3	350-353	for	_	_	
4-4	354-359	about	_	_	
4-5	360-361	1	_	_	
4-6	362-364	to	_	_	
4-7	365-367	10	_	_	
4-8	368-375	minutes	_	_	
4-9	375-376	,	_	_	
4-10	377-387	preferably	_	_	
4-11	388-392	from	_	_	
4-12	393-394	1	_	_	
4-13	395-397	to	_	_	
4-14	398-399	4	_	_	
4-15	400-407	minutes	_	_	
4-16	407-408	.	_	_	

#Text=After this heating period the solution is allowed to cool to 54.degree.
5-1	409-414	After	_	_	
5-2	415-419	this	_	_	
5-3	420-427	heating	_	_	
5-4	428-434	period	_	_	
5-5	435-438	the	_	_	
5-6	439-447	solution	_	_	
5-7	448-450	is	_	_	
5-8	451-458	allowed	_	_	
5-9	459-461	to	_	_	
5-10	462-466	cool	_	_	
5-11	467-469	to	_	_	
5-12	470-472	54	_	_	
5-13	472-473	.	_	_	
5-14	473-479	degree	_	_	
5-15	479-480	.	_	_	

#Text=C., which is preferable for primer hybridization.
6-1	481-482	C	_	_	
6-2	482-483	.	_	_	
6-3	483-484	,	_	_	
6-4	485-490	which	_	_	
6-5	491-493	is	_	_	
6-6	494-504	preferable	_	_	
6-7	505-508	for	_	_	
6-8	509-515	primer	_	_	
6-9	516-529	hybridization	_	_	
6-10	529-530	.	_	_	

#Text=The synthesis reaction may occur at a temperature ranging from room temperature up to a temperature above which the polymerase (inducing agent) no longer functions efficiently.
7-1	531-534	The	_	_	
7-2	535-544	synthesis	_	_	
7-3	545-553	reaction	_	_	
7-4	554-557	may	_	_	
7-5	558-563	occur	_	_	
7-6	564-566	at	_	_	
7-7	567-568	a	_	_	
7-8	569-580	temperature	_	_	
7-9	581-588	ranging	_	_	
7-10	589-593	from	_	_	
7-11	594-598	room	_	_	
7-12	599-610	temperature	_	_	
7-13	611-613	up	_	_	
7-14	614-616	to	_	_	
7-15	617-618	a	_	_	
7-16	619-630	temperature	_	_	
7-17	631-636	above	_	_	
7-18	637-642	which	_	_	
7-19	643-646	the	_	_	
7-20	647-657	polymerase	_	_	
7-21	658-659	(	_	_	
7-22	659-667	inducing	_	_	
7-23	668-673	agent	_	_	
7-24	673-674	)	_	_	
7-25	675-677	no	_	_	
7-26	678-684	longer	_	_	
7-27	685-694	functions	_	_	
7-28	695-706	efficiently	_	_	
7-29	706-707	.	_	_	

#Text=Thus, for example, if DNA polymerase is used, the temperature is generally no greater than about 40.degree.
8-1	708-712	Thus	_	_	
8-2	712-713	,	_	_	
8-3	714-717	for	_	_	
8-4	718-725	example	_	_	
8-5	725-726	,	_	_	
8-6	727-729	if	_	_	
8-7	730-733	DNA	_	_	
8-8	734-744	polymerase	_	_	
8-9	745-747	is	_	_	
8-10	748-752	used	_	_	
8-11	752-753	,	_	_	
8-12	754-757	the	_	_	
8-13	758-769	temperature	_	_	
8-14	770-772	is	_	_	
8-15	773-782	generally	_	_	
8-16	783-785	no	_	_	
8-17	786-793	greater	_	_	
8-18	794-798	than	_	_	
8-19	799-804	about	_	_	
8-20	805-807	40	_	_	
8-21	807-808	.	_	_	
8-22	808-814	degree	_	_	
8-23	814-815	.	_	_	

#Text=C.
9-1	816-817	C	_	_	
9-2	817-818	.	_	_	

#Text=The thermocycling is repeated until the desired amount of PCR product is produced.
10-1	819-822	The	_	_	
10-2	823-836	thermocycling	_	_	
10-3	837-839	is	_	_	
10-4	840-848	repeated	_	_	
10-5	849-854	until	_	_	
10-6	855-858	the	_	_	
10-7	859-866	desired	_	_	
10-8	867-873	amount	_	_	
10-9	874-876	of	_	_	
10-10	877-880	PCR	_	_	
10-11	881-888	product	_	_	
10-12	889-891	is	_	_	
10-13	892-900	produced	_	_	
10-14	900-901	.	_	_	

#Text=An exemplary PCR buffer comprises the following reagents: 50 mM KCl; 10 mM Tris-HCl at pH 8.3; 1.5 mM MgCl.sub.2; 0.001% (wt/vol) gelatin, 200 .mu.M dATP; 200 .mu.M dTTP; 200 .mu.M dCTP; 200 .mu.M dGTP; and 2.5 units Thermus aquaticus (Taq) DNA polymerase 1 per 100 microliters of buffer.
#Text=[0175] Suitable enzymes for elongating the primer sequences include, for example, E. coli DNA polymerase I, Taq DNA polymerase, Klenow fragment of E. coli DNA polymerase I, T4 DNA polymerase, other available DNA polymerases, reverse transcriptase, and other enzymes, including heat-stable enzymes, which will facilitate combination of the nucleotides in the proper manner to form the primer extension products which are complementary to each nucleic acid strand.
11-1	902-904	An	_	_	
11-2	905-914	exemplary	_	_	
11-3	915-918	PCR	_	_	
11-4	919-925	buffer	_	_	
11-5	926-935	comprises	_	_	
11-6	936-939	the	_	_	
11-7	940-949	following	_	_	
11-8	950-958	reagents	_	_	
11-9	958-959	:	_	_	
11-10	960-962	50	_	_	
11-11	963-965	mM	_	_	
11-12	966-969	KCl	_	_	
11-13	969-970	;	_	_	
11-14	971-973	10	_	_	
11-15	974-976	mM	_	_	
11-16	977-985	Tris-HCl	_	_	
11-17	986-988	at	_	_	
11-18	989-991	pH	_	_	
11-19	992-995	8.3	_	_	
11-20	995-996	;	_	_	
11-21	997-1000	1.5	_	_	
11-22	1001-1003	mM	_	_	
11-23	1004-1012	MgCl.sub	_	_	
11-24	1012-1014	.2	_	_	
11-25	1014-1015	;	_	_	
11-26	1016-1022	0.001%	_	_	
11-27	1023-1024	(	_	_	
11-28	1024-1026	wt	_	_	
11-29	1026-1027	/	_	_	
11-30	1027-1030	vol	_	_	
11-31	1030-1031	)	_	_	
11-32	1032-1039	gelatin	_	_	
11-33	1039-1040	,	_	_	
11-34	1041-1044	200	_	_	
11-35	1045-1046	.	_	_	
11-36	1046-1050	mu.M	_	_	
11-37	1051-1055	dATP	_	_	
11-38	1055-1056	;	_	_	
11-39	1057-1060	200	_	_	
11-40	1061-1062	.	_	_	
11-41	1062-1066	mu.M	_	_	
11-42	1067-1071	dTTP	_	_	
11-43	1071-1072	;	_	_	
11-44	1073-1076	200	_	_	
11-45	1077-1078	.	_	_	
11-46	1078-1082	mu.M	_	_	
11-47	1083-1087	dCTP	_	_	
11-48	1087-1088	;	_	_	
11-49	1089-1092	200	_	_	
11-50	1093-1094	.	_	_	
11-51	1094-1098	mu.M	_	_	
11-52	1099-1103	dGTP	_	_	
11-53	1103-1104	;	_	_	
11-54	1105-1108	and	_	_	
11-55	1109-1112	2.5	_	_	
11-56	1113-1118	units	_	_	
11-57	1119-1126	Thermus	_	_	
11-58	1127-1136	aquaticus	_	_	
11-59	1137-1138	(	_	_	
11-60	1138-1141	Taq	_	_	
11-61	1141-1142	)	_	_	
11-62	1143-1146	DNA	_	_	
11-63	1147-1157	polymerase	_	_	
11-64	1158-1159	1	_	_	
11-65	1160-1163	per	_	_	
11-66	1164-1167	100	_	_	
11-67	1168-1179	microliters	_	_	
11-68	1180-1182	of	_	_	
11-69	1183-1189	buffer	_	_	
11-70	1189-1190	.	_	_	
11-71	1191-1192	[	_	_	
11-72	1192-1196	0175	_	_	
11-73	1196-1197	]	_	_	
11-74	1198-1206	Suitable	_	_	
11-75	1207-1214	enzymes	_	_	
11-76	1215-1218	for	_	_	
11-77	1219-1229	elongating	_	_	
11-78	1230-1233	the	_	_	
11-79	1234-1240	primer	_	_	
11-80	1241-1250	sequences	_	_	
11-81	1251-1258	include	_	_	
11-82	1258-1259	,	_	_	
11-83	1260-1263	for	_	_	
11-84	1264-1271	example	_	_	
11-85	1271-1272	,	_	_	
11-86	1273-1274	E	_	_	
11-87	1274-1275	.	_	_	
11-88	1276-1280	coli	_	_	
11-89	1281-1284	DNA	_	_	
11-90	1285-1295	polymerase	_	_	
11-91	1296-1297	I	_	_	
11-92	1297-1298	,	_	_	
11-93	1299-1302	Taq	_	_	
11-94	1303-1306	DNA	_	_	
11-95	1307-1317	polymerase	_	_	
11-96	1317-1318	,	_	_	
11-97	1319-1325	Klenow	_	_	
11-98	1326-1334	fragment	_	_	
11-99	1335-1337	of	_	_	
11-100	1338-1339	E	_	_	
11-101	1339-1340	.	_	_	
11-102	1341-1345	coli	_	_	
11-103	1346-1349	DNA	_	_	
11-104	1350-1360	polymerase	_	_	
11-105	1361-1362	I	_	_	
11-106	1362-1363	,	_	_	
11-107	1364-1366	T4	_	_	
11-108	1367-1370	DNA	_	_	
11-109	1371-1381	polymerase	_	_	
11-110	1381-1382	,	_	_	
11-111	1383-1388	other	_	_	
11-112	1389-1398	available	_	_	
11-113	1399-1402	DNA	_	_	
11-114	1403-1414	polymerases	_	_	
11-115	1414-1415	,	_	_	
11-116	1416-1423	reverse	_	_	
11-117	1424-1437	transcriptase	_	_	
11-118	1437-1438	,	_	_	
11-119	1439-1442	and	_	_	
11-120	1443-1448	other	_	_	
11-121	1449-1456	enzymes	_	_	
11-122	1456-1457	,	_	_	
11-123	1458-1467	including	_	_	
11-124	1468-1479	heat-stable	_	_	
11-125	1480-1487	enzymes	_	_	
11-126	1487-1488	,	_	_	
11-127	1489-1494	which	_	_	
11-128	1495-1499	will	_	_	
11-129	1500-1510	facilitate	_	_	
11-130	1511-1522	combination	_	_	
11-131	1523-1525	of	_	_	
11-132	1526-1529	the	_	_	
11-133	1530-1541	nucleotides	_	_	
11-134	1542-1544	in	_	_	
11-135	1545-1548	the	_	_	
11-136	1549-1555	proper	_	_	
11-137	1556-1562	manner	_	_	
11-138	1563-1565	to	_	_	
11-139	1566-1570	form	_	_	
11-140	1571-1574	the	_	_	
11-141	1575-1581	primer	_	_	
11-142	1582-1591	extension	_	_	
11-143	1592-1600	products	_	_	
11-144	1601-1606	which	_	_	
11-145	1607-1610	are	_	_	
11-146	1611-1624	complementary	_	_	
11-147	1625-1627	to	_	_	
11-148	1628-1632	each	_	_	
11-149	1633-1640	nucleic	_	_	
11-150	1641-1645	acid	_	_	
11-151	1646-1652	strand	_	_	
11-152	1652-1653	.	_	_	

#Text=Generally, the synthesis will be initiated at the 3' end of each primer and proceed in the 5' direction along the template strand, until synthesis terminates, producing molecules of different lengths.
12-1	1654-1663	Generally	_	_	
12-2	1663-1664	,	_	_	
12-3	1665-1668	the	_	_	
12-4	1669-1678	synthesis	_	_	
12-5	1679-1683	will	_	_	
12-6	1684-1686	be	_	_	
12-7	1687-1696	initiated	_	_	
12-8	1697-1699	at	_	_	
12-9	1700-1703	the	_	_	
12-10	1704-1705	3	_	_	
12-11	1705-1706	'	_	_	
12-12	1707-1710	end	_	_	
12-13	1711-1713	of	_	_	
12-14	1714-1718	each	_	_	
12-15	1719-1725	primer	_	_	
12-16	1726-1729	and	_	_	
12-17	1730-1737	proceed	_	_	
12-18	1738-1740	in	_	_	
12-19	1741-1744	the	_	_	
12-20	1745-1746	5	_	_	
12-21	1746-1747	'	_	_	
12-22	1748-1757	direction	_	_	
12-23	1758-1763	along	_	_	
12-24	1764-1767	the	_	_	
12-25	1768-1776	template	_	_	
12-26	1777-1783	strand	_	_	
12-27	1783-1784	,	_	_	
12-28	1785-1790	until	_	_	
12-29	1791-1800	synthesis	_	_	
12-30	1801-1811	terminates	_	_	
12-31	1811-1812	,	_	_	
12-32	1813-1822	producing	_	_	
12-33	1823-1832	molecules	_	_	
12-34	1833-1835	of	_	_	
12-35	1836-1845	different	_	_	
12-36	1846-1853	lengths	_	_	
12-37	1853-1854	.	_	_	

#Text=The newly synthesized DNA strand and its complementary strand form a double-stranded molecule which can be used in the succeeding steps of the analysis process.
#Text=[0176] In one embodiment, the nucleotide sequence of the oligonucleotide tag is determined by measuring inorganic pyrophosphate (PPi) liberated from a nucleotide triphosphate (dNTP) as the dNMP is incorporated into an extended sequence primer.
13-1	1855-1858	The	_	_	
13-2	1859-1864	newly	_	_	
13-3	1865-1876	synthesized	_	_	
13-4	1877-1880	DNA	_	_	
13-5	1881-1887	strand	_	_	
13-6	1888-1891	and	_	_	
13-7	1892-1895	its	_	_	
13-8	1896-1909	complementary	_	_	
13-9	1910-1916	strand	_	_	
13-10	1917-1921	form	_	_	
13-11	1922-1923	a	_	_	
13-12	1924-1939	double-stranded	_	_	
13-13	1940-1948	molecule	_	_	
13-14	1949-1954	which	_	_	
13-15	1955-1958	can	_	_	
13-16	1959-1961	be	_	_	
13-17	1962-1966	used	_	_	
13-18	1967-1969	in	_	_	
13-19	1970-1973	the	_	_	
13-20	1974-1984	succeeding	_	_	
13-21	1985-1990	steps	_	_	
13-22	1991-1993	of	_	_	
13-23	1994-1997	the	_	_	
13-24	1998-2006	analysis	_	_	
13-25	2007-2014	process	_	_	
13-26	2014-2015	.	_	_	
13-27	2016-2017	[	*[1]	14-1[2_1]	
13-28	2017-2021	0176	*[1]	_	
13-29	2021-2022	]	*[1]	_	
13-30	2023-2025	In	*[1]	_	
13-31	2026-2029	one	*[1]	_	
13-32	2030-2040	embodiment	*[1]	_	
13-33	2040-2041	,	*[1]	_	
13-34	2042-2045	the	*[1]	_	
13-35	2046-2056	nucleotide	*[1]	_	
13-36	2057-2065	sequence	*[1]	_	
13-37	2066-2068	of	*[1]	_	
13-38	2069-2072	the	*[1]	_	
13-39	2073-2088	oligonucleotide	*[1]	_	
13-40	2089-2092	tag	*[1]	_	
13-41	2093-2095	is	*[1]	_	
13-42	2096-2106	determined	*[1]	_	
13-43	2107-2109	by	*[1]	_	
13-44	2110-2119	measuring	*[1]	_	
13-45	2120-2129	inorganic	*[1]	_	
13-46	2130-2143	pyrophosphate	*[1]	_	
13-47	2144-2145	(	*[1]	_	
13-48	2145-2148	PPi	*[1]	_	
13-49	2148-2149	)	*[1]	_	
13-50	2150-2159	liberated	*[1]	_	
13-51	2160-2164	from	*[1]	_	
13-52	2165-2166	a	*[1]	_	
13-53	2167-2177	nucleotide	*[1]	_	
13-54	2178-2190	triphosphate	*[1]	_	
13-55	2191-2192	(	*[1]	_	
13-56	2192-2196	dNTP	*[1]	_	
13-57	2196-2197	)	*[1]	_	
13-58	2198-2200	as	*[1]	_	
13-59	2201-2204	the	*[1]	_	
13-60	2205-2209	dNMP	*[1]	_	
13-61	2210-2212	is	*[1]	_	
13-62	2213-2225	incorporated	*[1]	_	
13-63	2226-2230	into	*[1]	_	
13-64	2231-2233	an	*[1]	_	
13-65	2234-2242	extended	*[1]	_	
13-66	2243-2251	sequence	*[1]	_	
13-67	2252-2258	primer	*[1]	_	
13-68	2258-2259	.	*[1]	_	

#Text=This method of sequencing, termed Pyrosequencing.TM. technology (PyroSequencing AB, Stockholm, Sweden) can be performed in solution (liquid phase) or as a solid phase technique.
14-1	2260-2264	This	*[2]	_	
14-2	2265-2271	method	*[2]	_	
14-3	2272-2274	of	_	_	
14-4	2275-2285	sequencing	_	_	
14-5	2285-2286	,	_	_	
14-6	2287-2293	termed	_	_	
14-7	2294-2311	Pyrosequencing.TM	_	_	
14-8	2311-2312	.	_	_	
14-9	2313-2323	technology	_	_	
14-10	2324-2325	(	_	_	
14-11	2325-2339	PyroSequencing	_	_	
14-12	2340-2342	AB	_	_	
14-13	2342-2343	,	_	_	
14-14	2344-2353	Stockholm	_	_	
14-15	2353-2354	,	_	_	
14-16	2355-2361	Sweden	_	_	
14-17	2361-2362	)	_	_	
14-18	2363-2366	can	_	_	
14-19	2367-2369	be	_	_	
14-20	2370-2379	performed	_	_	
14-21	2380-2382	in	_	_	
14-22	2383-2391	solution	_	_	
14-23	2392-2393	(	_	_	
14-24	2393-2399	liquid	_	_	
14-25	2400-2405	phase	_	_	
14-26	2405-2406	)	_	_	
14-27	2407-2409	or	_	_	
14-28	2410-2412	as	_	_	
14-29	2413-2414	a	_	_	
14-30	2415-2420	solid	_	_	
14-31	2421-2426	phase	_	_	
14-32	2427-2436	technique	_	_	
14-33	2436-2437	.	_	_	

#Text=PPi-based sequencing methods are described in, e.g., U.S.
15-1	2438-2447	PPi-based	_	_	
15-2	2448-2458	sequencing	_	_	
15-3	2459-2466	methods	_	_	
15-4	2467-2470	are	_	_	
15-5	2471-2480	described	_	_	
15-6	2481-2483	in	_	_	
15-7	2483-2484	,	_	_	
15-8	2485-2488	e.g	_	_	
15-9	2488-2489	.	_	_	
15-10	2489-2490	,	_	_	
15-11	2491-2494	U.S	_	_	
15-12	2494-2495	.	_	_	

#Text=Pat.
16-1	2496-2499	Pat	_	_	
16-2	2499-2500	.	_	_	

#Text=Nos. 6,274,320, 6258,568 and 6,210,891, WO9813523A1, Ronaghi, et al. (1996) Anal Biochem. 242:84-89, Ronaghi, et al. (1998) Science 281:363-365, and USSN 2001/0024790.
17-1	2501-2504	Nos	_	_	
17-2	2504-2505	.	_	_	
17-3	2506-2515	6,274,320	_	_	
17-4	2515-2516	,	_	_	
17-5	2517-2525	6258,568	_	_	
17-6	2526-2529	and	_	_	
17-7	2530-2539	6,210,891	_	_	
17-8	2539-2540	,	_	_	
17-9	2541-2552	WO9813523A1	_	_	
17-10	2552-2553	,	_	_	
17-11	2554-2561	Ronaghi	_	_	
17-12	2561-2562	,	_	_	
17-13	2563-2565	et	_	_	
17-14	2566-2568	al	_	_	
17-15	2568-2569	.	_	_	
17-16	2570-2571	(	_	_	
17-17	2571-2575	1996	_	_	
17-18	2575-2576	)	_	_	
17-19	2577-2581	Anal	_	_	
17-20	2582-2589	Biochem	_	_	
17-21	2589-2590	.	_	_	
17-22	2591-2594	242	_	_	
17-23	2594-2595	:	_	_	
17-24	2595-2597	84	_	_	
17-25	2597-2598	-	_	_	
17-26	2598-2600	89	_	_	
17-27	2600-2601	,	_	_	
17-28	2602-2609	Ronaghi	_	_	
17-29	2609-2610	,	_	_	
17-30	2611-2613	et	_	_	
17-31	2614-2616	al	_	_	
17-32	2616-2617	.	_	_	
17-33	2618-2619	(	_	_	
17-34	2619-2623	1998	_	_	
17-35	2623-2624	)	_	_	
17-36	2625-2632	Science	_	_	
17-37	2633-2636	281	_	_	
17-38	2636-2637	:	_	_	
17-39	2637-2640	363	_	_	
17-40	2640-2641	-	_	_	
17-41	2641-2644	365	_	_	
17-42	2644-2645	,	_	_	
17-43	2646-2649	and	_	_	
17-44	2650-2654	USSN	_	_	
17-45	2655-2659	2001	_	_	
17-46	2659-2660	/	_	_	
17-47	2660-2667	0024790	_	_	
17-48	2667-2668	.	_	_	

#Text=These disclosures of PPi sequencing are incorporated herein in their entirety, by reference.
18-1	2669-2674	These	_	_	
18-2	2675-2686	disclosures	_	_	
18-3	2687-2689	of	_	_	
18-4	2690-2693	PPi	_	_	
18-5	2694-2704	sequencing	_	_	
18-6	2705-2708	are	_	_	
18-7	2709-2721	incorporated	_	_	
18-8	2722-2728	herein	_	_	
18-9	2729-2731	in	_	_	
18-10	2732-2737	their	_	_	
18-11	2738-2746	entirety	_	_	
18-12	2746-2747	,	_	_	
18-13	2748-2750	by	_	_	
18-14	2751-2760	reference	_	_	
18-15	2760-2761	.	_	_	

#Text=See also, e.g., U.S.
19-1	2762-2765	See	_	_	
19-2	2766-2770	also	_	_	
19-3	2770-2771	,	_	_	
19-4	2772-2775	e.g	_	_	
19-5	2775-2776	.	_	_	
19-6	2776-2777	,	_	_	
19-7	2778-2781	U.S	_	_	
19-8	2781-2782	.	_	_	

#Text=Pat.
20-1	2783-2786	Pat	_	_	
20-2	2786-2787	.	_	_	

#Text=Nos. 6,210,891 and 6,258,568, each of which are fully incorporated herein by this reference.
#Text=[0177] Pyrophosphate can be detected by a number of different methodologies, and various enzymatic methods have been previously described (see e.g., Reeves, et al. (1969) Anal Biochem. 28:282-287; Guillory, et al. (1971) Anal Biochem. 39:170-180; Johnson, et al. (1968) Anal Biochem. 15:273; Cook, et al. 1978.
21-1	2788-2791	Nos	_	_	
21-2	2791-2792	.	_	_	
21-3	2793-2802	6,210,891	_	_	
21-4	2803-2806	and	_	_	
21-5	2807-2816	6,258,568	_	_	
21-6	2816-2817	,	_	_	
21-7	2818-2822	each	_	_	
21-8	2823-2825	of	_	_	
21-9	2826-2831	which	_	_	
21-10	2832-2835	are	_	_	
21-11	2836-2841	fully	_	_	
21-12	2842-2854	incorporated	_	_	
21-13	2855-2861	herein	_	_	
21-14	2862-2864	by	_	_	
21-15	2865-2869	this	_	_	
21-16	2870-2879	reference	_	_	
21-17	2879-2880	.	_	_	
21-18	2881-2882	[	_	_	
21-19	2882-2886	0177	_	_	
21-20	2886-2887	]	_	_	
21-21	2888-2901	Pyrophosphate	_	_	
21-22	2902-2905	can	_	_	
21-23	2906-2908	be	_	_	
21-24	2909-2917	detected	_	_	
21-25	2918-2920	by	_	_	
21-26	2921-2922	a	_	_	
21-27	2923-2929	number	_	_	
21-28	2930-2932	of	_	_	
21-29	2933-2942	different	_	_	
21-30	2943-2956	methodologies	_	_	
21-31	2956-2957	,	_	_	
21-32	2958-2961	and	_	_	
21-33	2962-2969	various	_	_	
21-34	2970-2979	enzymatic	_	_	
21-35	2980-2987	methods	_	_	
21-36	2988-2992	have	_	_	
21-37	2993-2997	been	_	_	
21-38	2998-3008	previously	_	_	
21-39	3009-3018	described	_	_	
21-40	3019-3020	(	_	_	
21-41	3020-3023	see	_	_	
21-42	3024-3027	e.g	_	_	
21-43	3027-3028	.	_	_	
21-44	3028-3029	,	_	_	
21-45	3030-3036	Reeves	_	_	
21-46	3036-3037	,	_	_	
21-47	3038-3040	et	_	_	
21-48	3041-3043	al	_	_	
21-49	3043-3044	.	_	_	
21-50	3045-3046	(	_	_	
21-51	3046-3050	1969	_	_	
21-52	3050-3051	)	_	_	
21-53	3052-3056	Anal	_	_	
21-54	3057-3064	Biochem	_	_	
21-55	3064-3065	.	_	_	
21-56	3066-3068	28	_	_	
21-57	3068-3069	:	_	_	
21-58	3069-3072	282	_	_	
21-59	3072-3073	-	_	_	
21-60	3073-3076	287	_	_	
21-61	3076-3077	;	_	_	
21-62	3078-3086	Guillory	_	_	
21-63	3086-3087	,	_	_	
21-64	3088-3090	et	_	_	
21-65	3091-3093	al	_	_	
21-66	3093-3094	.	_	_	
21-67	3095-3096	(	_	_	
21-68	3096-3100	1971	_	_	
21-69	3100-3101	)	_	_	
21-70	3102-3106	Anal	_	_	
21-71	3107-3114	Biochem	_	_	
21-72	3114-3115	.	_	_	
21-73	3116-3118	39	_	_	
21-74	3118-3119	:	_	_	
21-75	3119-3122	170	_	_	
21-76	3122-3123	-	_	_	
21-77	3123-3126	180	_	_	
21-78	3126-3127	;	_	_	
21-79	3128-3135	Johnson	_	_	
21-80	3135-3136	,	_	_	
21-81	3137-3139	et	_	_	
21-82	3140-3142	al	_	_	
21-83	3142-3143	.	_	_	
21-84	3144-3145	(	_	_	
21-85	3145-3149	1968	_	_	
21-86	3149-3150	)	_	_	
21-87	3151-3155	Anal	_	_	
21-88	3156-3163	Biochem	_	_	
21-89	3163-3164	.	_	_	
21-90	3165-3167	15	_	_	
21-91	3167-3168	:	_	_	
21-92	3168-3171	273	_	_	
21-93	3171-3172	;	_	_	
21-94	3173-3177	Cook	_	_	
21-95	3177-3178	,	_	_	
21-96	3179-3181	et	_	_	
21-97	3182-3184	al	_	_	
21-98	3184-3185	.	_	_	
21-99	3186-3190	1978	_	_	
21-100	3190-3191	.	_	_	

#Text=Anal Biochem. 91:557-565; and Drake, et al. (1979) Anal Biochem. 94: 117-120).
#Text=[0178] In one embodiment, PPi is detected enzymatically (e.g., by the generation of light).
22-1	3192-3196	Anal	_	_	
22-2	3197-3204	Biochem	_	_	
22-3	3204-3205	.	_	_	
22-4	3206-3208	91	_	_	
22-5	3208-3209	:	_	_	
22-6	3209-3212	557	_	_	
22-7	3212-3213	-	_	_	
22-8	3213-3216	565	_	_	
22-9	3216-3217	;	_	_	
22-10	3218-3221	and	_	_	
22-11	3222-3227	Drake	_	_	
22-12	3227-3228	,	_	_	
22-13	3229-3231	et	_	_	
22-14	3232-3234	al	_	_	
22-15	3234-3235	.	_	_	
22-16	3236-3237	(	_	_	
22-17	3237-3241	1979	_	_	
22-18	3241-3242	)	_	_	
22-19	3243-3247	Anal	_	_	
22-20	3248-3255	Biochem	_	_	
22-21	3255-3256	.	_	_	
22-22	3257-3259	94	_	_	
22-23	3259-3260	:	_	_	
22-24	3261-3264	117	_	_	
22-25	3264-3265	-	_	_	
22-26	3265-3268	120	_	_	
22-27	3268-3269	)	_	_	
22-28	3269-3270	.	_	_	
22-29	3271-3272	[	_	_	
22-30	3272-3276	0178	_	_	
22-31	3276-3277	]	_	_	
22-32	3278-3280	In	_	_	
22-33	3281-3284	one	_	_	
22-34	3285-3295	embodiment	_	_	
22-35	3295-3296	,	_	_	
22-36	3297-3300	PPi	_	_	
22-37	3301-3303	is	_	_	
22-38	3304-3312	detected	_	_	
22-39	3313-3326	enzymatically	_	_	
22-40	3327-3328	(	_	_	
22-41	3328-3331	e.g	_	_	
22-42	3331-3332	.	_	_	
22-43	3332-3333	,	_	_	
22-44	3334-3336	by	_	_	
22-45	3337-3340	the	_	_	
22-46	3341-3351	generation	_	_	
22-47	3352-3354	of	_	_	
22-48	3355-3360	light	_	_	
22-49	3360-3361	)	_	_	
22-50	3361-3362	.	_	_	

#Text=Such methods enable a nucleotide to be identified in a given target position, and the DNA to be sequenced simply and rapidly while avoiding the need for electrophoresis and the use of potentially dangerous radiolabels.
23-1	3363-3367	Such	_	_	
23-2	3368-3375	methods	_	_	
23-3	3376-3382	enable	_	_	
23-4	3383-3384	a	_	_	
23-5	3385-3395	nucleotide	_	_	
23-6	3396-3398	to	_	_	
23-7	3399-3401	be	_	_	
23-8	3402-3412	identified	_	_	
23-9	3413-3415	in	_	_	
23-10	3416-3417	a	_	_	
23-11	3418-3423	given	_	_	
23-12	3424-3430	target	_	_	
23-13	3431-3439	position	_	_	
23-14	3439-3440	,	_	_	
23-15	3441-3444	and	_	_	
23-16	3445-3448	the	_	_	
23-17	3449-3452	DNA	_	_	
23-18	3453-3455	to	_	_	
23-19	3456-3458	be	_	_	
23-20	3459-3468	sequenced	_	_	
23-21	3469-3475	simply	_	_	
23-22	3476-3479	and	_	_	
23-23	3480-3487	rapidly	_	_	
23-24	3488-3493	while	_	_	
23-25	3494-3502	avoiding	_	_	
23-26	3503-3506	the	_	_	
23-27	3507-3511	need	_	_	
23-28	3512-3515	for	_	_	
23-29	3516-3531	electrophoresis	_	_	
23-30	3532-3535	and	_	_	
23-31	3536-3539	the	_	_	
23-32	3540-3543	use	_	_	
23-33	3544-3546	of	_	_	
23-34	3547-3558	potentially	_	_	
23-35	3559-3568	dangerous	_	_	
23-36	3569-3580	radiolabels	_	_	
23-37	3580-3581	.	_	_	
